Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Biological Chemistry
Genentech will work with New York City-based Lodo Therapeutics to mine bacterial genomes for novel natural products. Deal specifics were not disclosed, but Lodo could get up to $969 million as projects progress. Lodo, which was one of C&EN’s 10 Start-ups to Watch in 2016, is based on methods developed by its cofounder, Rockefeller University chemist Sean Brady. His group searches bacterial genomes for gene clusters that encode for unique molecules with specific properties.
This article has been sent to the following recipient: